Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
144
Filing Date
Mar 11, 2026
Document Date
Mar 11, 2026
Form Description
Filed by "insiders" prior intended sale of restricted stock.
Filing Group
Other
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Stay in touch

You are now leaving 
the Dyne Therapeutics corporate website

Continue